1. Home
  2. FUL vs TARS Comparison

FUL vs TARS Comparison

Compare FUL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H. B. Fuller Company

FUL

H. B. Fuller Company

HOLD

Current Price

$58.47

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$79.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUL
TARS
Founded
1887
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FUL
TARS
Price
$58.47
$79.76
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$68.50
$73.63
AVG Volume (30 Days)
382.3K
438.7K
Earning Date
01-14-2026
11-04-2025
Dividend Yield
1.61%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$3,502,085,000.00
$366,100,000.00
Revenue This Year
N/A
$139.46
Revenue Next Year
$2.36
$49.91
P/E Ratio
$28.30
N/A
Revenue Growth
N/A
182.44
52 Week Low
$47.56
$38.51
52 Week High
$77.77
$83.47

Technical Indicators

Market Signals
Indicator
FUL
TARS
Relative Strength Index (RSI) 53.50 63.78
Support Level $55.08 $77.51
Resistance Level $59.43 $83.47
Average True Range (ATR) 1.44 3.56
MACD 0.27 0.26
Stochastic Oscillator 77.93 70.63

Price Performance

Historical Comparison
FUL
TARS

About FUL H. B. Fuller Company

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: